Take home message Weight-loss injections are designed as additional tools for weight management interventions and shouldnt be considered lifelong medications
13 In the EMPEROR-Reduced trial (ClinicalTrials.gov Identifier: NCT03057977), among patients with chronic HF New York Heart Association (NYHA) II to IV, the percentage of CVD-related death or HHF was lower in the group randomly assigned to receive empagliflozin (19.4%) compared with those assigned to receive placebo (24.7%
Contains high proportion of small neutral amino acids with tryptophan at N-terminus and glutamic acid at C-terminus giving net negative charge
Advanced Lab Testing Comprehensive panels covering metabolic, hormonal, thyroid, inflammation, nutrient, and lipid markers
Once prepared, it is generally stored under controlled refrigerated conditions (28C) and used within a limited time frame